UAB "Novo Nordisk Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data

Financial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
14,255,889 |
716,017 |
377,747 |
312,935 |
15,717 |
11.89 |
2.20 |
554,359 |
2,413,145 |
22,068 |
3,029,446 |
2022 |
---|
16,385,375 |
765,314 |
637,785 |
528,683 |
24,693 |
13.29 |
3.23 |
1,083,042 |
1,928,036 |
32,825 |
3,073,253 |
2023 |
---|
21,820,183 |
935,284 |
912,567 |
752,671 |
32,262 |
12.00 |
3.45 |
1,835,713 |
4,375,007 |
35,460 |
6,332,559 |
Register and
explore Okredo data2023 |
---|
21,820,183 |
935,284 |
912,567 |
752,671 |
32,262 |
12.00 |
3.45 |
1,835,713 |
4,375,007 |
35,460 |
6,332,559 |
Register and
explore Okredo data2023
Turnover (€)
21,820,183 €33 % *
Sales per employee (€)
935,284 €22 % *
Profit before tax (€)
912,567 €43 % *
Net Profit (€)
752,671 €42 % *
Profit per employee (€)
32,262 €31 % *
Total profitability (%)
12.00 %-9.71 % *
Net profitability (%)
3.45 %6.81 % *
Equity (€)
1,835,713 €70 % *
Amounts Payable And Liabilities (€)
4,375,007 €127 % *
Non-current Assets (€)
35,460 €8 % *
CurrentAssets (€)
6,332,559 €106 % *